Mo-BRUK (MBR) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
2 Sep, 2026Executive summary
Revenue for H1 2026 reached PLN 181.4 million, up 42.8% year-over-year, driven by core waste management operations and increased waste processing volumes.
Net profit for H1 2026 was PLN 42.2 million, a 59% increase from H1 2025.
The waste management segment generated 92% of total sales, remaining the core business driver.
Major organizational changes included the creation of SOLIDRA Sp. z o.o. and the acquisition of Eco Point, expanding into oils and oily water processing.
Significant contracts for hazardous waste removal and environmental remediation supported growth.
Financial highlights
EBITDA for H1 2026 was PLN 74.8 million, with a margin of 44.4%.
Operating profit rose to PLN 59.3 million from PLN 37.1 million year-over-year.
Consolidated net income for H1 2026 was PLN 42.2 million, impacted by higher depreciation, financial expenses, and tax.
Earnings per share increased to PLN 12.00 from PLN 7.55 year-over-year.
Net cash from operating activities was PLN 49.1 million, while net cash used in investing activities was PLN -56.0 million.
Outlook and guidance
Ongoing and forecasted contracts for environmental remediation projects (“environmental time bombs”) expected to support future revenue.
No significant seasonality expected; management sees limited impact from geopolitical instability in the Middle East.
Continued focus on expanding waste processing capacity, integrating recent acquisitions, and operational efficiency.
Latest events from Mo-BRUK
- Q1 2026 revenue up 32.6% with strong profit growth and segment expansion from investments.MBR
Q1 2026 - Record revenue and EBITDA growth in 2025, despite one-off charges, set up for further expansion.MBR
Q4 2025 - Innovative recycling processes and legal wins drive growth in sustainable building materials.MBR
Investor presentation - One-off write-down caused a net loss despite strong revenue and core business margins.MBR
Q3 2025 - Record sales and EBITDA in 2024, with major investments boosting capacity and future growth.MBR
Q4 2024 - Revenue and EBITDA rose in H1 2025, driven by medical waste and capacity expansion.MBR
Q2 2025 - Revenue up 18% y/y, net profit down 10.6% as capacity and margins improve.MBR
Q3 2024 - H1 2024 revenue up 7.2% to PLN 120.2m, but profit fell on higher costs and plant downtime.MBR
Q2 2024 - Revenue and EBITDA rose, but net profit fell amid higher costs and legal risks.MBR
Q1 2025